July 31, 2010
| Bio-IT World

Industry Trends
Loading...

The “Net Innovation Trend” and What It Means for Big Pharmas, Biotechs, and Generics

By Mark P. Mathieu
Innovation is the key value driver in healthcare.  Over the past 8 years, the pharmaceuticals sector has lost a stunning $593 billion (-65%) in market cap while the two sectors with innovation – biotech and med tech – have each added $71 billion (+46%) and $19 billion (+6%) in market cap, respectively.  Read More


Top Headlines


Complete Genomics Files $86-Million IPO
TODAY |

San Jose Mercury News | Next-generation sequencing service provider Complete Genomics has filed papers for an initial public offering (IPO) that could be worth $86 million. The company's proposed stock ticker symbol is GNOM.

more
2010 Best Practices Awards Winners
|

Bio-IT World | Last April, we handed out the Bio•IT World 2010 Best Practices Awards at a lavish awards ceremony in Boston during the Bio-IT World Conference & Expo. Here you’ll find profiles of the six category winners and three other awards: the Editors’ Choice Award, the Judges’ Prize, and a Community Service Award.

more
Helicos and Integromics Identify New Class of Short RNA in Human Cells
|

Bio-IT World | Spain’s sizzling summer continues: an historic triumph in the World Cup, a victory at Wimbledon, and for Madrid-based Integromics, its first paper in Nature, a collaboration with Helicos that describes a new class of short RNA.  

more
Get Adobe Flash player
Dell Buys Ocarina
|

ZDNet | Dell is buying deduplication startup Ocarina, winner of the 2010 Bio-IT World Best of Show award in IT Hardware and Infrastructure.

more
Generic Drug Approvals Picking Up?
|

Forbes | The FDA approved Novartis' generic blood thinner after a four-year review, maybe signaling more generic approvals in the coming year.

more
Sanofi-Aventis Bids for Genzyme--Updated
|

Bloomberg | Over the weekend, rumors swirled that Sanofi-Aventis had made a bid for Genzyme about two weeks ago. Today, however Bloomberg has reported that Genzyme has rebuffed the approach last week.

more






White Papers & Special Reports

oracle20723
The Role of Analytics in Transforming Healthcare
Sponsored by Oracle

Sharing many of the data challenges and opportunities faced by Healthcare, the Life Sciences industry remains focused on delivering new, innovative therapies and solutions to patients in a cost effective, timely and safe way. With spiraling R&D costs, new methods such as adaptive trials, and never ending need for deep pharmacovigilance, the Life Sciences companies that effectively use analytics to explore, monitor and optimize their business will rapidly become the new leaders.

Oracle’s strategy—built upon Enterprise Health Analytics and Health Data Warehouse Foundation—provides a powerful, practical, and extensible approach to delivering the IT analytics infrastructure required to confront the worldwide healthcare challenge.

pegasystems
BPM-Based Case Management Approach to Optimizing Clinical Trial Efficiency
Sponsored by Pegasystems

Business Process Management (BPM) software offers liberation in the planning and management of clinical trials today. SmartBPM provides the components for automating critical clinical trial processes ranging from protocol development and patient enrollment to site management and investigator payments. Advantages are:

  • Potentially stunning return on investment at multiple levels.
  • A 500%, or better, increase in application development time by directly executing business requirements
  • Improved customer retention
  • A 50% possible reduction in training time

Discovered is opportunity to enhance relationships with investigators, subjects, and regulators while bringing momentum to a technology-impaired study startup phase. Learn more about SmartBPM in this complimentary white paper.

Cmed paper
Next-gen Cloud-based eClinical
Sponsored by Cmed Technology

New technologies are available to leverage Cloud Computing in  managing clinical trial data. This paper discusses a next generation eClinical
platform that:

  • Speeds trial set up
  • Accommodates changes with zero downtime
  • Integrates effectively with other clinical trial technology systems

It is offered with either software-as-a-service (SaaS), or turnkey infrastructure options in which the user organization operates their own cloud using their IT teams, within their data centers. Read this paper to learn and decide how best to leverage cloud computing’s many strengths for your organization’s  particular needs.



Expert Comment

Loading...

The Data Side of Accelerated Biocomputing

By Martin Gollery

May 18, 2010 | Intel and AMD have boosted the number of cores in their high-end server chips yet again. A single node in a cluster may now have dozens of cores. Meanwhile, accelerated computers using hardware like FPGAs or GPGPUs have hundreds or even thousands of cores available to the applications that have been ported to them. So why do your analysis jobs still take so long? Read more.

Bio-IT World invites contributed Expert Commentaries. Contact Kevin Davies with proposals.

Life Science Webcasts & Podcasts

Medidata Solutions

Evaluating a Risk-based Approach to Good Clinical Practice 

medidata5_podcastThe verification of source documents by study monitors at investigational sites is considered a good clinical practice by regulatory authorities overseeing clinical research, and is extremely important to ensuring data quality in clinical trials. Today’s challenging environment is prompting study teams to explore the use of risk-based approaches to monitoring that do not compromise data quality, but allow limited resources to be directed more effectively to where they’re most needed and to the most critical review activities.

In this podcast, industry experts and executives from Medidata will address questions such as:

  • Why are regulatory agencies and industry open to evaluating the new approaches in site monitoring and source document verification (SDV), and what attitudes and reactions towards less than 100% SDV?
  • What factors do research sponsors need to consider in adopting risk-based site monitoring?


Download Now 


Loading...
Linked in          Twitter


Bio-IT Briefs

| Bio-IT World | FULL STORIES


Current Issue
Current Issue
Job Openings

mskc logo
Software Engineer – Computational Biology Center

Memorial Sloan-Kettering Cancer Center seeks an Engineer to design and develop complex data analysis systems in support of cancer genomics research projects at the Computational Biology Center. Qualified candidate will have a BA, 5+ years of software development experience and expert knowledge of Java, SQL, and HTML.

Apply: www.mskcciscareers.org.  Equal opportunity and affirmative action employer.

Loading...

For reprints and/or copyright permission, please contact The YGS Group, 3650 West Market Street, York, PA;

(717) 505-9701 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.